In practice, this peptide needs less frequent dosing while still helping the pituitary stay responsive
Pyridoxine compared to other semaglutide compound additives Pyridoxine is not the only additive used in compounded semaglutide
NICE technology appraisal guidance (TA1026) covers its use for weight management in England, again subject to eligibility criteria, specialist service referral, and local commissioning and supply [16] Orlistat an older, orally administered option available on NHS prescription in primary care Access to GLP-1 and dual agonist therapies for weight management is currently via specialist services and remains subject to NICE criteria, local commissioning decisions, and ongoing supply considerations
References van der Kolk JH, Thomas S, Mach N, Ramseyer A, Burger D, Gerber V, Nuoffer JM